Tridhya Tech Limited
TRIDHYA (NSE) · ISIN INE0LWY01029 · Software Products · listed 2023
Not on any surveillance list
In Q2 FY25 (quarter to 30 September 2024, standalone), revenue was ₹21.24 cr and profit after tax ₹0.69 cr.
Next: Board meeting: financial results on 31 October 2026.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY25 standalone | ₹21.24 cr | ₹0.69 cr | 0.30 | 24 Oct 2024 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹44.51 cr | ₹67.74 cr | ₹116.57 cr |
| 30 Sep 2025 standalone | ₹42.16 cr | ₹68.32 cr | ₹116.95 cr |
| 31 Mar 2025 standalone | ₹44.06 cr | ₹91.14 cr | ₹141.05 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 63.40% | 0.00% | 0.00% | 36.60% |
Latest filings
- Annual Report FY2025-26 (New) 7 September 2026 · NSE
- Tridhya Tech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026. 5 September 2026 · NSE
- Declaration of Audited Standalone and Consolidated Financial Results of the company for the half year and financial year ended on 31st March, 2026 along with Auditors Report thereon. 27 May 2026 · NSE
- Tridhya Tech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 27 May 2026 · NSE
- Tridhya Tech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. 14 November 2025 · NSE
Other companies in Software Products
- Oracle Financial Services Software Limited
- Nucleus Software Exports Limited
- Tanla Platforms Limited
- C.E. Info Systems Limited
- Ramco Systems Limited
- Subex Limited
- Quick Heal Technologies Limited
- Capillary Technologies India Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.